Absence of the CAAX endoprotease Rce1: Effects on cell growth and transformation

被引:114
作者
Bergo, MO
Ambroziak, P
Gregory, C
George, A
Otto, JC
Kim, E
Nagase, H
Casey, PJ
Balmain, A
Young, SG
机构
[1] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA
[2] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA
[5] San Francisco Gen Hosp, Med Serv, San Francisco, CA 94110 USA
[6] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
关键词
D O I
10.1128/MCB.22.1.171-181.2002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
After isoprenylation, the Ras proteins and other CAAX proteins undergo two additional enzymatic modifications-endoproteolytic release of the last three amino acids of the protein by the protease Rce1 and methylation of the carboxyl-terminal isoprenylcysteine by the methyltransferase Icmt. This postisoprenylation processing is thought to be important for the association of Ras proteins with membranes. Blocking postisoprenylation processing, by inhibiting Rce1 has been suggested as a potential approach for retarding cell growth and blocking cellular transformation. The objective of this study was to develop a cell culture system for addressing these issues. We generated mice with a conditional Rce1 allele (Rce1(flox)) and produced Rce1(flox/flox) fibroblasts. Cre-mediated excision of Rce1 (thereby producing Rce1(flox) fibroblasts) eliminated Ras endoproteolytic processing and methylation and caused a partial mislocalization of truncated K-Ras and H-Ras fusion proteins within cells. Rce1(Delta/Delta) fibroblasts grew more slowly than Rce1(flox/flox) fibroblasts. The excision of Reel also reduced Ras-induced transformation, as judged by the growth of colonies in soft agar. The excision of Rce1 from a Rce1(flox/flox) skin carcinoma cell line also significantly retarded the growth of cells, and this effect was exaggerated by cotreatment of the cells with a farnesyltransferase inhibitor. These studies support the idea that interference with postisoprenylation processing retards cell growth, limits Ras-induced transformation, and sensitizes tumor cells to a farnesyltransferase inhibitor.
引用
收藏
页码:171 / 181
页数:11
相关论文
共 40 条
  • [21] METHYLATION AND PROTEOLYSIS ARE ESSENTIAL FOR EFFICIENT MEMBRANE-BINDING OF PRENYLATED P21K-RAS(B)
    HANCOCK, JF
    CADWALLADER, K
    MARSHALL, CJ
    [J]. EMBO JOURNAL, 1991, 10 (03) : 641 - 646
  • [22] RESCUE OF THE EN-1 MUTANT PHENOTYPE BY REPLACEMENT OF EN-1 WITH EN-2
    HANKS, M
    WURST, W
    ANSONCARTWRIGHT, L
    AUERBACH, AB
    JOYNER, AL
    [J]. SCIENCE, 1995, 269 (5224) : 679 - 682
  • [23] Resistance of K-RasB(V12) proteins to farnesyltransferase inhibitors in Rat1 cells
    James, G
    Goldstein, JL
    Brown, MS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) : 4454 - 4458
  • [24] ISOPRENOID ADDITION TO RAS PROTEIN IS THE CRITICAL MODIFICATION FOR ITS MEMBRANE ASSOCIATION AND TRANSFORMING ACTIVITY
    KATO, K
    COX, AD
    HISAKA, MM
    GRAHAM, SM
    BUSS, JE
    DER, CJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) : 6403 - 6407
  • [25] TUMORIGENICITY OF FIBROBLAST LINES EXPRESSING THE ADENOVIRUS E1A, CELLULAR P53, OR NORMAL C-MYC GENES
    KELEKAR, A
    COLE, MD
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (01) : 7 - 14
  • [26] Disruption of the mouse Rce1 gene results in defective Ras processing and mislocalization of Ras within cells
    Kim, E
    Ambroziak, P
    Otto, JC
    Taylor, B
    Ashby, M
    Shannon, K
    Casey, PJ
    Young, SG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) : 8383 - 8390
  • [27] PROTEIN FARNESYLTRANSFERASE INHIBITORS BLOCK THE GROWTH OF RAS-DEPENDENT TUMORS IN NUDE-MICE
    KOHL, NE
    WILSON, FR
    MOSSER, SD
    GIULIANI, E
    DESOLMS, SJ
    CONNER, MW
    ANTHONY, NJ
    HOLTZ, WJ
    GOMEZ, RP
    LEE, TJ
    SMITH, RL
    GRAHAM, SL
    HARTMAN, GD
    GIBBS, JB
    OLIFF, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) : 9141 - 9145
  • [28] Non-Ras targets of farnesyltransferase inhibitors: focus on Rho
    Lebowitz, PF
    Prendergast, GC
    [J]. ONCOGENE, 1998, 17 (11) : 1439 - 1445
  • [29] RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors
    Liu, AX
    Du, W
    Liu, JP
    Jessell, TM
    Prendergast, GC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (16) : 6105 - 6113
  • [30] Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice
    Liu, M
    Bryant, MS
    Chen, JP
    Lee, SN
    Yaremko, B
    Li, ZJ
    Dell, J
    Lipari, P
    Malkowski, M
    Prioli, N
    Rossman, RR
    Korfmacher, WA
    Nomeir, AA
    Lin, CC
    Mallams, AK
    Doll, RJ
    Catino, JJ
    Girijavallabhan, VM
    Kirschmeier, P
    Bishop, WR
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (01) : 50 - 58